Michael Abraham, MD
Neurology · Kansas City, KSNPI 1689791196
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,937 of the $48,311 with a category attached, or 62.0%. 21 manufacturers reported payments, led by Stryker at 47.2% of the total. Reporting peaked in 2019 at $17,882 and has fallen 66.8% since, to $5,933 in 2025. Among neurology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $420.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$23K
- Penumbra, Inc.$15K
- Imperative Care, Inc$4K
- Qapel Medical Inc$2K
- Rapid Medical Ltd$2K
- Johnson & Johnson$617
- plus $1K from 15 others
Across 15 payments — averaging $10,341 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$71K
- Route 92 Medical, Inc.$49K
- Stryker$35K
What the payments were for
- Consulting fees$29,93762%
- Speaking & faculty fees$8,40017%
- Travel & lodging$4,2889%
- Food & beverage$5,68712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 34 | $22,784 |
| Penumbra, Inc. | 29 | $15,071 |
| Imperative Care, Inc | 6 | $3,867 |
| Qapel Medical Inc | 2 | $2,444 |
| Rapid Medical Ltd | 14 | $2,090 |
| Johnson & Johnson | 7 | $617 |
| Route 92 Medical, Inc. | 3 | $316 |
| Microvention, Inc. | 3 | $294 |
| Medtronic(2 entities) | 2 | $285 |
| Microtransponder, Inc. | 2 | $190 |
| Genentech, Inc. | 1 | $77 |
| Cordis US CORP. | 2 | $51 |
| Trisalus Life Sciences, Inc. | 2 | $47 |
| Inspiremd Ltd | 1 | $33 |
| Amylyx Pharmaceuticals, Inc. | 1 | $27 |
| CSL Behring | 1 | $25 |
| Sanofi | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| AbbVie | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $18 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$15,449
- TREVO$9,325
- INFINITY$5,263
- FLOWGATE$4,463
- POD$3,751
- ZOOM 88-T LARGE DISTAL PLATFORM$3,664
- SURPASS EVOLVE$2,833
- NEUROFORM ATLAS$2,400
- SYNCHRO SELECT$2,400
- AXS CATALYST 7$2,079
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$1,867
- COMANECI 17$1,867
- ATLAS$1,663
- CATALYST$1,663
- EXCELSIOR$1,663
- AXS VECTA 71$1,615
- AXS INFINITY LS$700
- NEW PRODUCT DEVELOPMENT$350
- Pipeline$285
- WEB$273
How this compares
$48,311 in reported general payments places this provider in the 90th percentile of 131 neurology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 27 | $19,543 |
| Lacosamide | 11 | $731 |
| ClopidogrelClopidogrel Bisulfate | 29 | $469 |
| Oxcarbazepine | 12 | $328 |
| Atorvastatin Calcium | 14 | $221 |
| Sumatriptan Succinate | 22 | $215 |
| Amitriptyline Hcl | 15 | $162 |
| Gabapentin | 20 | $133 |
| Topiramate | 15 | $105 |
| Nortriptyline Hcl | 22 | $92 |
| Pregabalin | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other neurology in Kansas City
- Ivan OsorioKansas City$101.7M
- Rajesh PahwaKansas City$889K
- Richard DubinskyKansas City$122K
- Jeffrey BurnsKansas City$115K
- Amanda ThuringerKansas City$87K
- Mamatha PasnoorKansas City$86K
- Constantine FarmakidisKansas City$25K
- Andrew CreedKansas City$16K
- James AppelbaumKansas City$15K
- Patrick LandazuriKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.